🟢 Quantum BioPharma is trading 12.75% up today after FDA cleared Lucid-MS IND for Phase 2 trial

Quantum BioPharma is trading 12.75% up now at $3.89 after the FDA cleared its Investigational New Drug application for Lucid-MS, enabling a Phase 2 trial for progressive multiple sclerosis.

• Trial start-up activities, including site selection, are underway; enrollment and drug administration could begin quickly.
• The FDA milestone is a direct, company-specific catalyst for the August 10, 2026 gain.